X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ONCOLOGY RESEARCH

期刊標題檢索 ONCOL RES 最新評論: What method (2024-09-18)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ONCOLOGY RESEARCH]您好,您是該頁面的第 73966 位訪客。

期刊簡介
期刊名稱ONCOLOGY RESEARCH ONCOLOGY RESEARCH
LetPub Score
6.2
50 ratings
Rate

Reputation
5.3

Influence
6.4

Speed
8.2

期刊簡稱ONCOL RES
ISSN0965-0407
E-ISSN1555-3906
h-index52
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.400.4720.473
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q2189 / 404
Category: Medicine
Subcategory: Cancer Research
Q3142 / 230

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.
官方網站https://www.cognizantcommunication.com/journal-titles/oncology-research
在線稿件提交 orjournal@gmail.com
開放訪問No
出版商Cognizant Communication Corporation
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年1992
每年文章數72每年文章數趨勢
黃金OA百分比94.57%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ3221/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0965-0407%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 3 Month(s)
競爭力 *來自作者的數據: About 75%
參考鏈接
相關期刊 【ONCOLOGY RESEARCH】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS330897
    CANCER RESEARCH312133
    BMC CANCER245484
    Asian Pacific Journal of Cancer Prevention219152
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH198015
    INTERNATIONAL JOURNAL OF CANCER191629
    CLINICAL CANCER RESEARCH181666
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY176364
    ONCOLOGY REPORTS175029
    CA-A CANCER JOURNAL FOR CLINICIANS163631
  •  

    ONCOLOGY RESEARCH ONCOLOGY RESEARCH
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)
  [ONCOLOGY RESEARCH] 的評論撰寫評論
作者: zhaian


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-18 13:46:29 評論於
What method
(0) 讚! | zhaian

作者: 桃花永莲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-10 17:42:54 評論於
It is said that the papers issued by Chinese hospitals are all from paper mills, and each one is accurate when checked.
(0) 讚! | 桃花永莲

作者: 浙江梁天宇


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-06-23 00:00:10 評論於
The estimated time for completion is around 2 months.
(0) 讚! | 浙江梁天宇

作者: 浙江梁天宇


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-06-22 23:59:32 評論於
This publication pays attention to the submission methods.
(0) 讚! | 浙江梁天宇

作者: Spencer Terry


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-28 20:40:52 評論於
How long does the review process for this journal usually take? It has been two weeks in the "in review" stage. Does anyone have any experiences to share about submitting articles?
(0) 讚! | Spencer Terry

作者: 123minmin


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-23 21:59:47 評論於
Hey guys, is the submission website for this journal the email address indicated above?
(0) 讚! | 123minmin

作者: Lilith Albert


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-28 17:33:38 評論於
Why is the impact factor decreasing so much?
(0) 讚! | Lilith Albert

作者: 七伤沛山


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-08 08:47:33 評論於
Escape
(0) 讚! | 七伤沛山

作者: 江南己未


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-16 19:30:30 評論於
When will we receive the proof and when will it be available online?
(0) 讚! | 江南己未

作者: 暴风刘新


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-11 22:45:08 評論於
May I ask what the submission process is like? I sent an email a few days ago but have not heard back yet
(0) 讚! | 暴风刘新

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:51:48 評論於
Graphical Abstract can be translated as "图文摘要". The function of the graphical abstract is similar to the abstract of a paper, but it does not have to be as detailed. Instead, it highlights the highlights or interesting points of the text, attracting readers and helping them to understand the full text at a glance, and also serving as a form of promotion
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:45:06 評論於
According to the requirements of the journal, but not all journals have the same requirements
(0) 讚! | 维尔娜菲茨杰拉德

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 16:00:58 評論於
What is a Graphical Abstract?
(0) 讚! | 八坂篷蔚

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 18:18:09 評論於
Do submissions have to include a graphical abstract?
(0) 讚! | 上清雨真

作者: 茂典baby


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-11-22 11:09:05 評論於
How long is the first review period?
(0) 讚! | 茂典baby

作者: 筑阳俊捷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-10-23 14:00:27 評論於
A $50.00 non refundable submission fee is required when your manuscript is sent out for review. You will also be asked to confirm that, if your manuscript is accepted for publication, you will pay the relatively inexpensive open access fee of $600.00 for less than 5 pages, or $1,000.00 for 5–12 pages and $50.00 for each additional page over 12 when billed at proof stage
(0) 讚! | 筑阳俊捷

作者: 筑阳俊捷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-10-19 21:05:26 評論於
How much is the layout fee?
(0) 讚! | 筑阳俊捷

作者: 笑真姑娘


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-10-03 19:30:24 評論於
Has been blacklisted by multiple hospitals
(0) 讚! | 笑真姑娘

作者: 碧水旭露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-09-25 15:50:10 評論於
Please translate the following paragraph into English and Japanese, and use ":" and ":" as the titles
(0) 讚! | 碧水旭露

作者: 华清凝莲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-09-19 22:54:01 評論於
Where is it written?
(0) 讚! | 华清凝莲

作者: 华清凝莲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-09-19 16:31:58 評論於
Yes
(0) 讚! | 华清凝莲

作者: Marsh Laurie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-09-09 14:26:42 評論於
Chinese hospitals have been caught fabricating research papers, it's over
(0) 讚! | Marsh Laurie

作者: 虚徒天心


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-08-24 09:03:26 評論於
Do we need to pay $50 first for this magazine to review our submission?
(0) 讚! | 虚徒天心

作者: 华清凝莲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-08-07 08:18:49 評論於
Review Speed: 2.0 | Submission Success Rate: 50.0 Experience Sharing: Reversing Drug Resistance in Breast Cancer
(0) 讚! | 华清凝莲

作者: 华清凝莲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-08-07 08:10:45 評論於
The article has been published
(0) 讚! | 华清凝莲

首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)

開始撰寫 [ONCOLOGY RESEARCH] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*